British FMCG major RB Plc on Tuesday said its toilet cleaning product Harpic has reached over 2 crore more households in India following a change in consumer behaviour with health and hygiene segment becoming primary segment.
Besides, the company has also seen an increase in sales of its sexual wellbeing brand, Durex, during the July-September quarter in emerging markets such as India and China.
“In India, we have seen a continued increase in the penetration of Harpic following behaviour change campaigns, with over 20m (million) more households using the brand compared to last year,” said RB in a post earning statement.
Moreover, the company has also reported an increase in sales of its sexual well-being brand Durex during the July-September quarter in the emerging markets as China and India.
“In sexual wellbeing, Durex has gained share in both China and India, key emerging markets for the business,” said RB adding the “improved performances” from Durex was benefited from the recovery in markets.
Earlier, RB had reported a decline in sales of Durex brand in the January-June (H1) period in the global market.
In addition to the overall favourable market backdrop, the strong LFL (Like for like) growth reflects good market share gains in a number of key categories, with consumers favouring trusted brands in times of uncertainty.
“In particular, Dettol, Lysol, Finish, Durex and Gaviscon all gained share in key markets year-to-date,” it said.
RB (Reckitt Benckiser) owns several brands such as Clearasil, Enfa, Lysol, Veet, Dettol, Air Wick, Durex, Mortein, Cillit Bang, Nurofen, Nutramigen, Scholl,